Uttar Pradesh: Man's severed leg used as pillow in hospital

Kanpur, Jul 8: The Special Task Force (STF) shot dead Amar Dubey in an encounter in Maudaha on Wednesday morning. Amar, a right hand man of gangster Vikas Dubey, who shot dead eight police personnel on Friday last, figured prominently in the list of wanted persons released by the Kanpur police on Tuesday.

He was a named accused in the massacre.

According to STF sources, the police team had received a tip off about Amar's presence in the district and when they tried to close in on him, the criminal opened fire on them, He was killed in retaliatory firing around 6.30.a.m,

Amar was reportedly heading towards the house of one of his relatives in Maudaha area.

"We asked him to surrender but he opened fire at us and was killed when we returned the fire," said an STF official.

Earlier, he had been hiding in Faridabad but moved out after police pressure increased there.

Amar Dubey was a trusted accomplice of Vikas Dubey and the police had announced a reward of Rs 25,000 on him after the Kanpur massacre.

Incidentally, reports claim that Vikas Dubey was also seen at a hotel in Faridabad on Tuesday night but fled before the police could close in on him.

India's COVID-19 tally raced past the seven lakh-mark with 22,252 fresh infections on Tuesday, five days after crossing the six lakh post, while the death toll climbed to 20,160 as 467 more people succumbed to the disease, according to the Union health ministry.

With this, the country has recorded over 20,000 cases of the infection for the fifth consecutive day.

India's coronavirus infection caseload stands at 7,19,665, the ministry's data updated at 8 am showed.

With a steady rise, the number of recoveries stands at 4,39,947, while there are 2,59,557 active cases of coronavirus infection in the country.

"Thus, around 61.13 % of patients have recovered so far," an official said.

The total number of confirmed cases also includes foreigners.

Of the 467 deaths reported in the last 24 hours, 204 are from Maharashtra, 61 from Tamil Nadu, 48 from Delhi, 29 from Karnataka, 24 from Uttar Pradesh, 22 from West Bengal, 17 from Gujarat.

Telangana and Haryana reported 11 deaths each; Madhya Pradesh nine; Andhra Pradesh seven; Jammu and Kashmir six; Rajasthan and Punjab five each; Bihar, Kerala and Odisha two each; and Arunachal Pradesh and Jharkhand one each.

Washington, May 19: As the scientists across the world are struggling to develop a vaccine for combating coronavirus, US drugmaker Moderna announced on Monday (local time) that the phase I trial of its Covid-19 vaccine has shown positive early results.

The company is hopeful that it's vaccine could be available to the public as early as January next year. Several firms across the world are in the race to develop a vaccine for the deadly virus which has claimed over 3 lakh lives worldwide.

CNN citing Dr. Tal Zaks, Moderna's chief medical officer reported that "if future studies go well, the company's vaccine could be available to the public as early as January".

"This is absolutely good news and news that we think many have been waiting for for quite some time," Zaks was quoted as saying.

Moderna, based in Cambridge, Massachusetts announced that the vaccine developed neutralising antibodies to the virus at levels reaching or exceeding the levels seen in people who have naturally recovered from Covid-19, reported CNN.

These will be followed by phase 2 trials and phase 3 trials, which Moderna plans to start in July.

President Donald Trump had on Friday said that that the United States will be able to deliver a few hundred million doses of COVID-19 vaccine, under 'Operation Warp Speed', by the end of this year.

"I have very recently seen early data from a clinical trial with a coronavirus vaccine and this data made me feel even more confident that we'll be able to deliver a few hundred million doses of vaccine by the end of 2020 and we will do the best we can," Trump had said at a press conference at the White House on Friday.